Literature DB >> 19393630

Conformational detection of p53's oligomeric state by FlAsH Fluorescence.

Tawnya M Webber1, Andrew C Allen, Wai Kit Ma, Rhett G Molloy, Charisse N Kettelkamp, Caitlin A Dow, Matthew J Gage.   

Abstract

The p53 tumor suppressor protein is a critical checkpoint in prevention of tumor formation, and the function of p53 is dependent on proper formation of the active tetramer. In vitro studies have shown that p53 binds DNA most efficiently as a tetramer, though inactive p53 is predicted to be monomeric in vivo. We demonstrate that FlAsH binding can be used to distinguish between oligomeric states of p53, providing a potential tool to explore p53 oligomerization in vivo. The FlAsH tetra-cysteine binding motif has been incorporated along the dimer and tetramer interfaces in the p53 tetramerization domain to create reporters for the dimeric and tetrameric states of p53, though the geometry of the four cysteines is critical for efficient FlAsH binding. Furthermore, we demonstrate that FlAsH binding can be used to monitor tetramer formation in real-time. These results demonstrate the potential for using FlAsH fluorescence to monitor protein-protein interactions in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19393630      PMCID: PMC2743378          DOI: 10.1016/j.bbrc.2009.04.073

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

1.  Fluorescent labeling of recombinant proteins in living cells with FlAsH.

Authors:  B A Griffin; S R Adams; J Jones; R Y Tsien
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

2.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

3.  Four p53 DNA-binding domain peptides bind natural p53-response elements and bend the DNA.

Authors:  P Balagurumoorthy; H Sakamoto; M S Lewis; N Zambrano; G M Clore; A M Gronenborn; E Appella; R E Harrington
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

4.  Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms.

Authors:  P D Jeffrey; S Gorina; N P Pavletich
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

5.  Characterization of p53 oligomerization domain mutations isolated from Li-Fraumeni and Li-Fraumeni like family members.

Authors:  M E Lomax; D M Barnes; T R Hupp; S M Picksley; R S Camplejohn
Journal:  Oncogene       Date:  1998-08-06       Impact factor: 9.867

6.  Characterization of the oligomerization defects of two p53 mutants found in families with Li-Fraumeni and Li-Fraumeni-like syndrome.

Authors:  T S Davison; P Yin; E Nie; C Kay; C H Arrowsmith
Journal:  Oncogene       Date:  1998-08-06       Impact factor: 9.867

7.  Participation of p53 protein in the cellular response to DNA damage.

Authors:  M B Kastan; O Onyekwere; D Sidransky; B Vogelstein; R W Craig
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

8.  Specific sequences from the carboxyl terminus of human p53 gene product form anti-parallel tetramers in solution.

Authors:  H Sakamoto; M S Lewis; H Kodama; E Appella; K Sakaguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

9.  Cross-strand split tetra-Cys motifs as structure sensors in a beta-sheet protein.

Authors:  Beena Krishnan; Lila M Gierasch
Journal:  Chem Biol       Date:  2008-10-20

10.  Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours.

Authors:  T G Graeber; C Osmanian; T Jacks; D E Housman; C J Koch; S W Lowe; A J Giaccia
Journal:  Nature       Date:  1996-01-04       Impact factor: 49.962

View more
  2 in total

1.  Amyloid-β forms fibrils by nucleated conformational conversion of oligomers.

Authors:  Jiyong Lee; Elizabeth K Culyba; Evan T Powers; Jeffery W Kelly
Journal:  Nat Chem Biol       Date:  2011-07-31       Impact factor: 15.040

2.  Crystallization and Biophysical Approaches for Studying the Interactions Between the Vps4-MIT Domain and ESCRT-III Proteins.

Authors:  Takayuki Obita; Rieko Kojima; Mineyuki Mizuguchi
Journal:  Methods Mol Biol       Date:  2019
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.